George Stefanis, MD
Neurological Surgery · Macon, GANPI 1578666780
Payments from drug & device makers
Across 38 payments — averaging $30.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$209
- Boston Scientific$165
- Edwards Lifesciences$117
- IBSA Pharma Inc.$94
- Kyocera Medical Technologies, Inc.$94
- Smith+Nephew$88
- plus $386 from 14 others
What the payments were for
- Food & beverage$1,154100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $209 |
| Boston Scientific | 2 | $165 |
| Edwards Lifesciences | 1 | $117 |
| IBSA Pharma Inc. | 5 | $94 |
| Kyocera Medical Technologies, Inc. | 2 | $94 |
| Smith+Nephew | 1 | $88 |
| AstraZeneca | 4 | $67 |
| Si-bone, Inc. | 3 | $61 |
| Providence Medical Technology, Inc. | 2 | $34 |
| Shionogi Inc | 2 | $33 |
| Electronic Waveform Lab, Inc. | 1 | $23 |
| Medtronic | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Averitas Pharma Inc. | 1 | $22 |
| Terumo Medical Corporation | 1 | $20 |
| Zimvie Inc. | 1 | $16 |
| Zimmer Biomet | 1 | $16 |
| Pfizer | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$124
- ClearSight System$117
How this compares
$1,154 in reported general payments places this provider in the 25th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Piroxicam | 31 | $17,680 |
| Calcipotriene | 38 | $16,681 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 479 | $7,809 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 358 | $5,905 |
| Pregabalin | 340 | $4,787 |
| Tizanidine Hcl | 300 | $3,671 |
| Methocarbamol | 204 | $2,780 |
| Gabapentin | 241 | $2,337 |
| Lidocaine | 19 | $2,169 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 123 | $1,992 |
| Tramadol Hcl | 379 | $1,826 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $1,195 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 31 | $1,076 |
| Baclofen | 45 | $707 |
| Methylprednisolone | 80 | $570 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Macon
- Igor de CastroMacon$450K
- Joe RobinsonMacon$192K
- Kevin StevensonMacon$62K
- Regis HaidAtlanta$25.5M
- Rishi GuptaMarietta$3.5M
- John CowanRome$3.2M
- Thomas MorrisonAtlanta$2.8M
- Arthur GrigorianAtlanta$2M
- Christopher TomarasAtlanta$1.5M
- Betsy GrunchGainesville$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.